Publicaciones en las que colabora con Marina Sabaté Brescó (9)

2024

  1. Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 1, pp. 195-200

2023

  1. Medical algorithm: Diagnosis and management of histaminergic angioedema

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Angioedema severity and impact on quality of life: Chronic histaminergic angioedema versus chronic spontaneous urticaria

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 11, pp. 3039-3043.e3

  2. Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines

    Clinical and Experimental Allergy

  3. SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity

    Frontiers in Allergy, Vol. 3

  4. Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens

    Annals of Allergy, Asthma and Immunology, Vol. 128, Núm. 3, pp. 283-290.e4

2021

  1. A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 6, pp. 2284-2292

  2. The multifaceted mas‐related g protein‐coupled receptor member x2 in allergic diseases and beyond

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

2019

  1. Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1